Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-beta gene family
- PMID: 3322813
- PMCID: PMC553836
- DOI: 10.1002/j.1460-2075.1987.tb02700.x
Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-beta gene family
Abstract
Human glioblastoma cells secrete a peptide, termed glioblastoma-derived T cell suppressor factor (G-TsF), which has suppressive effects on interleukin-2-dependent T cell growth. As shown here, complementary DNA for G-TsF reveals that G-TsF shares 71% amino acid homology with transforming growth factor-beta (TGF-beta). In analogy to TGF-beta it is apparently synthesized as the carboxy-terminal end of a precursor polypeptide which undergoes proteolytic cleavage to yield the 112 amino-acid-long mature form of G-TsF. Comparison of the amino-terminal sequence of G-TsF with that of porcine TGF-beta 2 and bovine cartilage-inducing factor B shows complete homology, which indicates that we have cloned the human analogue of these factors. It is tempting to consider a role for G-TsF in tumor growth where it may enhance tumor cell proliferation in an autocrine way and/or reduce immunosurveillance of tumor development.
Similar articles
-
Immunosuppression and transforming growth factor-beta in glioblastoma. Preferential production of transforming growth factor-beta 2.J Immunol. 1989 Nov 15;143(10):3222-9. J Immunol. 1989. PMID: 2809198
-
The glioblastoma-derived T cell suppressor factor/transforming growth factor-beta 2 inhibits T cell growth without affecting the interaction of interleukin 2 with its receptor.Eur J Immunol. 1988 Apr;18(4):593-600. doi: 10.1002/eji.1830180416. Eur J Immunol. 1988. PMID: 2452745
-
T cell suppressor factor from human glioblastoma cells is a 12.5-kd protein closely related to transforming growth factor-beta.EMBO J. 1987 Jun;6(6):1633-6. doi: 10.1002/j.1460-2075.1987.tb02411.x. EMBO J. 1987. PMID: 3497030 Free PMC article.
-
Expression of TGF-beta 2 in human glioblastoma: a role in resistance to immune rejection?Ciba Found Symp. 1991;157:232-8; discussion 238-41. doi: 10.1002/9780470514061.ch15. Ciba Found Symp. 1991. PMID: 1649035 Review.
-
The failure of current immunotherapy for malignant glioma. Tumor-derived TGF-beta, T-cell apoptosis, and the immune privilege of the brain.Brain Res Brain Res Rev. 1995 Sep;21(2):128-51. doi: 10.1016/0165-0173(95)00010-0. Brain Res Brain Res Rev. 1995. PMID: 8866671 Review.
Cited by
-
Transforming growth factor beta signaling and craniofacial development: modeling human diseases in zebrafish.Front Cell Dev Biol. 2024 Feb 7;12:1338070. doi: 10.3389/fcell.2024.1338070. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 38385025 Free PMC article. Review.
-
Transforming growth factor-beta: possible roles in carcinogenesis.Br J Cancer. 1988 Jun;57(6):594-600. doi: 10.1038/bjc.1988.135. Br J Cancer. 1988. PMID: 3044431 Free PMC article. Review.
-
Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant glioma.Semin Immunol. 2008 Oct;20(5):267-75. doi: 10.1016/j.smim.2008.04.001. Epub 2008 Jun 9. Semin Immunol. 2008. PMID: 18539480 Free PMC article. Review.
-
Transforming growth factors beta 1 and beta 2 are differentially expressed in fibrotic liver disease.Am J Pathol. 1991 Dec;139(6):1221-9. Am J Pathol. 1991. PMID: 1750499 Free PMC article.
-
Recombinant production, purification, crystallization, and structure analysis of human transforming growth factor β2 in a new conformation.Sci Rep. 2019 Jun 17;9(1):8660. doi: 10.1038/s41598-019-44943-4. Sci Rep. 2019. PMID: 31209258 Free PMC article.
References
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials